Psoriasis Relief Cream
MAGIC OF MAHONIA AQUIFOLIUM AND RELIEVA
This Canadian invention involves a patented extraction process that increases the concentration of the beneficial alkaloids from Mahonia Aquifolium an ancient Indian Herbal remedy 75 times creating its proprietary extract “Psorberine”. Reliéva™ is an anti-inflammatory, antibacterial crème for the treatment of psoriasis and atopic dermatitis. It provides immediate relief for itching, irritation ands inflammation associated with almost all problem skin conditions with ZERO TOXICITY AND IRRITATION.
The active component Psorberine™ consists of enriched alkaloids, extracted from the root of the plant Mahonia Aquifolium. The efficacy of the Reliéva™ crème was successfully tested in clinical studies on more than 500 patients with psoriasis or atopic dermatitis. With an efficacy that is at least comparable to standard therapies, Relieva™ displays a clearly superior side effect profile and apparently does not lose its effects after repeated applications.
RESEARCH AND PRODUCT DEVELOPMENT
In excess of $4,000,000 has been spent on published clinical trials, university and laboratory studies.
Psorberine™ is clinically proven to heal symptoms of most widespread skin conditions including psoriasis and eczema;
- preventing cell proliferation, scaling and flaking resulting in smoothing skin
- relieving itching,
- relieving inflammation and pain associated with these symptoms
Relieva™ Meets all North American Regulatory requirements !
Health Canada recognized claims for the following items
- NPN 80002614 skin lotion
- NPN 80008473 skin cream
World Wide Recognition for Safety and Efficacy !
British Herbal Pharmacopeias
- American Homeopathic Pharmacopoea
- European Herbal Pharmacopea
- Relieva approved in AUSTRALIA
Distinct Competitive Advantages of Relieva™over the Leading Pharmaceuticals with sales of a $1.4 billion
Does not lose efficacy overtime
- Diseases and skin conditions do not build up tolerability to treatment
- Zero irritancy proven milder than Dove soap in irritancy studies
- Unparallel combination of Safety and Efficacy
Clinical Proof - Published Clinicals
Reliéva® proven effective and safe in a 200 patient, Double Blind Placebo Controlled Study recently published in the American Journal of Therapeutics (13,121-126, 2006).
Clinical trial proves Relieva® very effective and safe for eczema and atopic dermatitis published in American Journal of Theraputics (14,442-446, 2007)
Eczema market is three times greater than psoriasis estimated at $21 billion annually.
Eczema and Psoriasis apart from acne are the most difficult skin conditions to treat with millions of patients young and old seeking treatment everyday. Relieva has been recognized in clinical trials published by the American Journal of Therapeutics for its effectiveness in treating these diseases with virtually no side effects associated with prescriptions and steroid creams.
There is no product available in this collection.